A new injectable medicine is giving hope to people with asthma by helping them breathe better. The drug, called dupilumab ...

THIS AUTUMN, Paris, France, hosted the 34ᵗʰ annual European Academy of Dermatology and Venereology (EADV) Congress.

An anti-inflammation injectable drug called dupilumab can reduce mucus buildup and improve breathing among asthma patients, a ...

A cohort study finds no significant differences in height among children with inflammatory diseases treated with JAK ...

GSK now owns the global development and commercialisation rights to Empirico's COPD-targeting (siRNA) oligonucleotide, ...

Regeneron (REGN) reported $3.75 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 0.9%. EPS of $11.83 for the same period compares to $12.46 a year ago ...

Dupixent (dupilumab) has been a breakthrough treatment for people with severe eczema, asthma, and other inflammatory ...

Regeneron Pharmaceuticals and Sanofi SA have initiated a new clinical study titled ‘An Open-Label, Single-Arm Study to Assess Growth and Bone Mineral Density in Children ≥6 to ...

Determining a biologic's duration of use to treat pediatric atopic dermatitis has several factors, according to Lawrence ...

There are some 40 interleukins that play a wide variety of roles in inflammation and the body’s immune response, some of them hitting the accelerator and others tapping the brakes. When it comes to ...